Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 21;25(1):1119.
doi: 10.1186/s12913-025-13283-7.

Health provider perspectives on differentiated service delivery for HIV in Oyo state, Nigeria: exploring the experiences of service providers from a demand perspective

Affiliations

Health provider perspectives on differentiated service delivery for HIV in Oyo state, Nigeria: exploring the experiences of service providers from a demand perspective

Adelaja Modupe Gift et al. BMC Health Serv Res. .

Abstract

Background: Differentiated Service Delivery (DSD) models have been introduced to optimise HIV care by adapting services to client needs while reducing the burden on healthcare systems. In Nigeria, where HIV prevalence remains high. Understanding provider perspectives is critical to improving and sustaining DSD implementation. This study explored the experiences, challenges, and recommendations of healthcare providers involved in DSD delivery in Ibadan North, Oyo State.

Methods: A qualitative descriptive study was conducted between July and September 2024, involving 11 key informant interviews and two focus group discussions across three DSD-implementing facilities. Participants included clinicians, ART counsellors, HTS providers, retention officers, and program managers. Data were analysed thematically using NVivo 12 software, following the Consolidated Criteria for Reporting Qualitative Research (COREQ) guidelines.

Results: Five core themes emerged: perceived benefits of DSD models, implementation challenges, eligibility and suitability of clients, human resource capacity and training, and strategic recommendations for sustainability. Providers reported that DSD models improved accessibility, reduced clinic congestion, and enhanced patient retention and viral suppression. However, challenges such as inaccurate client data, dependency on community models, systemic inefficiencies, and inadequate training impeded effective implementation. Participants emphasised the need for policy alignment, community engagement, capacity building, and stronger monitoring systems.

Conclusion: DSD models hold promise for improving HIV service delivery in Nigeria. However, their success depends on addressing structural and operational challenges, tailoring approaches to local contexts, and strengthening health workforce capacity. These findings provide critical insights to inform national policy, support program scale-up, and contribute to achieving the UNAIDS 95-95-95 and SDG 3.3 targets.

Keywords: ART adherence; Antiretroviral therapy; Differentiated service delivery; HIV care; Nigeria; Patient retention; Qualitative study.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Ethical approval for this study was obtained from the Oyo State Ministry of Health Research Ethics Committee (Ref: AD 13/479/879) and the Lead City University Research Ethics Committee (Ref: LCU-REC/24/130). The study was conducted in full accordance with the ethical principles outlined in the Declaration of Helsinki for research involving human participants. All participants received detailed information about the study in English and Yoruba to ensure full understanding. Written informed consent was obtained from all participants prior to participation. Participants were informed of their right to decline or withdraw from the study at any time without penalty. Consent for publication: Not Applicable. Competing interests: The authors declare no competing interests.

Similar articles

References

    1. World Health Organization. HIV and AIDS. 2024.
    1. AIDS PG. Global HIV/AIDS Overview. 2025.
    1. Gayle HD, Hill GL. Global impact of human immunodeficiency virus and AIDS. Clin Microbiol Rev. 2001;14(2):327–35. - PMC - PubMed
    1. Payagala S, Pozniak A. The global burden of HIV. Clin Dermatol. 2024;42(2):119–27. - PubMed
    1. Kumah E, Boakye DS, Boateng R, Agyei E. Advancing the global fight against hiv/aids: strategies, barriers, and the road to eradication. Annals Global Health. 2023;89(1):83. - PMC - PubMed

LinkOut - more resources